Drug makers feel relieved over stronger Korean won

Published: 2007-11-05 06:55:00

Updated: 2007-11-05 06:55:00

Korean pharmaceutical firms are breathing a sign of relief as the Korean won remains strong against major currencies, in the midst of external negative factors – government’s relented price cut and rebate scandal.

In particular, the weak yen is encouraging local drug makers to bring more Japan...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK